BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38254997)

  • 1. Association of Genetic Markers with the Risk of Early-Onset Breast Cancer in Kazakh Women.
    Skvortsova L; Abdikerim S; Yergali K; Mit N; Perfilyeva A; Omarbayeva N; Zhunussova A; Kachiyeva Z; Sadykova T; Bekmanov B; Kaidarova D; Djansugurova L; Zhunussova G
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of BRCA1/2 gene and pathologic characteristics from Kazakh population with sporadic breast cancer in northwestern China.
    Yang SY; Aisimutula D; Li HF; Hu Y; Du X; Li J; Luan MX
    Genet Mol Res; 2015 Oct; 14(4):13151-61. PubMed ID: 26535628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity.
    Zhunussova G; Omarbayeva N; Kaidarova D; Abdikerim S; Mit N; Kisselev I; Yergali K; Zhunussova A; Goncharova T; Abdrakhmanova A; Djansugurova L
    Oncotarget; 2023 Oct; 14():860-877. PubMed ID: 37791908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome wide SNP genotyping study in the Tunisian population: specific reporting on a subset of common breast cancer risk loci.
    Hamdi Y; Ben Rekaya M; Jingxuan S; Nagara M; Messaoud O; Benammar Elgaaied A; Mrad R; Chouchane L; Boubaker MS; Abdelhak S; Boussen H; Romdhane L
    BMC Cancer; 2018 Dec; 18(1):1295. PubMed ID: 30594178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
    Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL
    BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
    Wendt C; Margolin S
    Acta Oncol; 2019 Feb; 58(2):135-146. PubMed ID: 30606073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
    Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
    Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.
    Arason A; Gunnarsson H; Johannesdottir G; Jonasson K; Bendahl PO; Gillanders EM; Agnarsson BA; Jönsson G; Pylkäs K; Mustonen A; Heikkinen T; Aittomäki K; Blomqvist C; Melin B; Johannsson OT; Møller P; Winqvist R; Nevanlinna H; Borg A; Barkardottir RB
    Breast Cancer Res; 2010; 12(4):R50. PubMed ID: 20637093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
    Shattuck-Eidens D; Oliphant A; McClure M; McBride C; Gupte J; Rubano T; Pruss D; Tavtigian SV; Teng DH; Adey N; Staebell M; Gumpper K; Lundstrom R; Hulick M; Kelly M; Holmen J; Lingenfelter B; Manley S; Fujimura F; Luce M; Ward B; Cannon-Albright L; Steele L; Offit K; Thomas A
    JAMA; 1997 Oct; 278(15):1242-50. PubMed ID: 9333265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.
    Yassaee VR; Zeinali S; Harirchi I; Jarvandi S; Mohagheghi MA; Hornby DP; Dalton A
    Breast Cancer Res; 2002; 4(4):R6. PubMed ID: 12100744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
    Cini G; Mezzavilla M; Della Puppa L; Cupelli E; Fornasin A; D'Elia AV; Dolcetti R; Damante G; Bertok S; Miolo G; Maestro R; de Paoli P; Amoroso A; Viel A
    BMC Med Genet; 2016 Feb; 17():11. PubMed ID: 26852130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found.
    Hartikainen JM; Tuhkanen H; Kataja V; Dunning AM; Antoniou A; Smith P; Arffman A; Pirskanen M; Easton DF; Eskelinen M; Uusitupa M; Kosma VM; Mannermaa A
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):75-80. PubMed ID: 15668479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity.
    Juwle A; Saranath D
    Med Oncol; 2012 Dec; 29(5):3272-81. PubMed ID: 22752604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation.
    Abdel-Qadir H; Thavendiranathan P; Fung K; Amir E; Austin PC; Anderson GS; Lee DS
    JAMA Netw Open; 2019 Sep; 2(9):e1911838. PubMed ID: 31539076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer.
    Zagami P; Fernandez-Martinez A; Rashid NU; Hoadley KA; Spears PA; Curigliano G; Perou CM; Carey LA
    JAMA Netw Open; 2023 Dec; 6(12):e2348814. PubMed ID: 38117494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.